Elixiron Immunotherapeutics Reports Positive Phase 2 Interim Results for Enrupatinib: Evidence of Neuroinflammation Reduction and Early Cognitive Benefit in Alzheimer's Disease

Elixiron Immunotherapeutics Reports Positive Phase 2 Interim Results for Enrupatinib: Evidence of Neuroinflammation Reduction and Early Cognitive Benefit in Alzheimer's Disease

CAMBRIDGE, Mass. and TAIPEI, June 11, 2026 /PRNewswire/ -- Elixiron Immunotherapeutics (TPEx: 7871), a clinical-stage biopharmaceutical company pioneering precision immunotherapy for neurodegenerative and autoimmune diseases, today announced...

POP Culture Group Reports Stellar Half-Year Results: Robust Business Growth with Revenue Surging 141% Year-Over-Year

POP Culture Group Reports Stellar Half-Year Results: Robust Business Growth with Revenue Surging 141% Year-Over-Year

XIAMEN, China, June 10, 2026 /PRNewswire/ -- POP Culture Group Co., Ltd. (Nasdaq: CPOP, "POP Culture" or the "Company"), today announced its unaudited financial results for six months ended December 31, 2025. During the reporting period, the Company...

OceanaGold Reports Voting Results from its 2026 Annual Meeting of Shareholders

OceanaGold Reports Voting Results from its 2026 Annual Meeting of Shareholders

VANCOUVER, BC, June 10, 2026 /PRNewswire/ -- OceanaGold Corporation (TSX: OGC) (NYSE: OGC) ("OceanaGold" or the "Company") is pleased to report the voting results from the Annual General and Special Meeting of Shareholders of the Company (the "AGM")...

Acer Reports May Revenues at NT$26.17 Billion, a Record High in May in 13 Years, up 36.5% Year-on-year

Acer Reports May Revenues at NT$26.17 Billion, a Record High in May in 13 Years, up 36.5% Year-on-year

TAIPEI, June 9, 2026 /PRNewswire/ -- Acer Inc. (TWSE: 2353) announced its consolidated revenues for May at NT$26.17 billion with growth of 36.5% year-on-year (YoY). Consolidated revenues for year-to-May reached NT$129.91 billion with 31.0% growth...

Zepp Health Corporation Reports First Quarter of 2026 Unaudited Financial Results

Zepp Health Corporation Reports First Quarter of 2026 Unaudited Financial Results

MILPITAS, Calif., June 9, 2026 /PRNewswire/ -- Zepp Health Corporation ("Zepp" or the "Company") (NYSE: ZEPP) today announced its unaudited financial results for the first quarter of 2026. First Quarter of 2026 Financial and Operating Highlights:...

Pictor® Reports Strong Commercial Momentum One Year After Launching U.S. Headquarters

Pictor® Reports Strong Commercial Momentum One Year After Launching U.S. Headquarters

The targeted proteomic platform company marks its first anniversary in Carlsbad with four commercial partnerships, seven products, BSL-2 equipped lab, and growing adoption across human and animal health markets globally CARLSBAD, Calif., June 2,...

TCI EXPRESS Reports Steady Growth in Q4 & FY2026; Surpasses One Million Tonnes of Cargo and Maintains Debt-Free Balance Sheet

TCI EXPRESS Reports Steady Growth in Q4 & FY2026; Surpasses One Million Tonnes of Cargo and Maintains Debt-Free Balance Sheet

GURUGRAM, India, June 1, 2026 /PRNewswire/ -- TCI Express Ltd. ("TCI EXPRESS", NSE: TCIEXP; BSE: 540212), India's leading express distribution company, today announced its audited financial results for the quarter and year ended March 31, 2026....

NYSE Content Update: Dell Technologies Reports 88% Revenue Increase YoY

NYSE Content Update: Dell Technologies Reports 88% Revenue Increase YoY

NYSE issues a pre-market daily advisory direct from the trading floor. NEW YORK, May 29, 2026 /PRNewswire/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today's NYSE Pre-market...

Noah Reports Q1 2026 Earnings: Transformation Momentum Continues, Driven by Scalable AI Breakthroughs and Long-Term Growth Engines

Noah Reports Q1 2026 Earnings: Transformation Momentum Continues, Driven by Scalable AI Breakthroughs and Long-Term Growth Engines

AI integration and disciplined expansion drive operating margin to 37.8% Domestic business refocusing on long-term investments; RMB-denominated private secondary products increased 63.6% year-over-year Global network transitions from license...

XPENG Reports Q1 2026 Results: Gross Margin Sustains High Level of 20.6%, Accelerating Physical AI Mass Production, Commercialization and Globalization

XPENG Reports Q1 2026 Results: Gross Margin Sustains High Level of 20.6%, Accelerating Physical AI Mass Production, Commercialization and Globalization

First-quarter revenue totaled RMB 13.03 billion. Quarterly gross margin reached 20.6%. Overseas deliveries surpassed 6,000 units for the first time in April, targeting sustained monthly overseas deliveries above 10,000 units in Q4. The Ultra trim...

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • ...
  • 18
  • menu
    menu